We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+6.93%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$262M
AUM Growth
+$52.1M
Cap. Flow
+$36.5M
Cap. Flow %
13.94%
Top 10 Hldgs %
72.18%
Holding
59
New
13
Increased
28
Reduced
6
Closed
5
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWB icon
26
iShares Russell 1000 ETF
IWB
$49.1B
$1.66M 0.63%
16,051
+1,268
+9% +$125K
BIIB icon
27
Biogen
BIIB
$32.3B
$1.51M 0.58%
5,416
XLB icon
28
State Street Materials Select Sector SPDR ETF
XLB
$8.81B
$1.33M 0.51%
57,560
+1,960
+4% +$43.1K
XLU icon
29
State Street Utilities Select Sector SPDR ETF
XLU
$21.9B
$1.22M 0.46%
63,996
+6,456
+11% +$123K
DBC icon
30
Invesco DB Commodity Index Tracking Fund
DBC
$1.82B
$1.21M 0.46%
47,002
+39,155
+499% +$1M
RLY icon
31
State Street Multi-Asset Real Return ETF
RLY
$1.35B
$1.16M 0.44%
+39,917
New +$1.16M
SJNK icon
32
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.8B
$1.13M 0.43%
36,542
+1,724
+5% +$53K
CMBS icon
33
iShares CMBS ETF
CMBS
$472M
$1.11M 0.43%
21,785
+805
+4% +$41.3K
EBND icon
34
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.29B
$1.09M 0.42%
+36,814
New +$1.11M
SRLN icon
35
State Street Blackstone Senior Loan ETF
SRLN
$5.48B
$724K 0.28%
14,469
-6,337
-30% -$317K
DSI icon
36
iShares MSCI KLD 400 Social ETF
DSI
$5.53B
$710K 0.27%
20,550
RGLS
37
DELISTED
Regulus Therapeutics
RGLS
$402K 0.15%
+453
New +$390K
BOND icon
38
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.55B
$378K 0.14%
3,610
-6,579
-65% -$697K
DLN icon
39
WisdomTree US LargeCap Dividend Fund
DLN
$6.35B
$278K 0.11%
8,354
VNQ icon
40
Vanguard Real Estate ETF
VNQ
$38.6B
$246K 0.09%
+3,810
New +$255K
SZYM
41
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$223K 0.09%
20,500
+5,500
+37% +$54.1K
WPM icon
42
Wheaton Precious Metals
WPM
$69.6B
$212K 0.08%
+10,500
New +$228K
SQNM
43
DELISTED
SEQUENOM INC NEW
SQNM
$211K 0.08%
90,000
+50,000
+125% +$119K
NBIX icon
44
Neurocrine Biosciences
NBIX
$15.7B
$204K 0.08%
+21,865
New +$213K
SAND
45
DELISTED
Sandstorm Gold
SAND
$160K 0.06%
+37,500
New +$179K
IMUC
46
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$65K 0.02%
1,750
SGYP
47
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$56K 0.02%
+10,140
New +$43.7K
EXK
48
Endeavour Silver
EXK
$3.19B
$51K 0.02%
+14,000
New +$54.5K
ANV
49
DELISTED
Allied Nevada Gold Corp
ANV
$50K 0.02%
+14,000
New +$52.5K
IAG icon
50
IAMGOLD
IAG
$11.8B
$47K 0.02%
+14,000
New +$60.7K

Similar funds

Callan Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Callan Capital held 59 positions worth $262M, up 25% from $210M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Callan Capital deployed $36.5M of net new capital in Q4 2013, opening 13 new positions and adding to 28 existing holdings. Its largest new stake was RECEPTOS INC COM STK (DE): 594,142 shares worth $17.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 98% of assets, down from 98% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was PIMCO Active Bond Exchange-Traded Fund, an estimated $697K trimmed.

  • Callan Capital's largest Q4 2013 buy was RECEPTOS INC COM STK (DE): 594,142 shares worth $17.2M.
  • Callan Capital added most to State Street SPDR S&P Dividend ETF in Q4 2013, an estimated $3.49M increase.
  • Callan Capital's biggest Q4 2013 reduction was PIMCO Active Bond Exchange-Traded Fund, cutting an estimated $697K.
  • Callan Capital fully exited Vanguard Short-Term Bond ETF in Q4 2013, selling an estimated $504K.
  • Callan Capital's ten largest holdings make up 72% of its $262M portfolio in Q4 2013.
  • Callan Capital opened 13 new positions and closed 5 in Q4 2013.
  • Callan Capital's portfolio value rose 25% quarter-over-quarter to $262M.

Based on Callan Capital's 13F filing for Q4 2013, filed 12 Feb 2014.